We are live on ! Find out more
CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

1 hedge funds and large institutions have $0 invested in Cascadian Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 91 → 1 (-90)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $152M → $0 (-$152M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 90

Holders
1
Holders Change
-90
Holders Change %
-98.9%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
90
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$33.5M
2
BG
Baupost Group
Massachusetts
-$32.3M
3
BI
BVF Inc
California
-$11.6M
4
BlackRock
BlackRock
New York
-$10.1M
5
ACA
Avoro Capital Advisors
New York
-$9.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
– -$33.5M -9,064,575 Closed
BG
2
Baupost Group
Massachusetts
– -$32.3M -8,721,079 Closed
BI
3
BVF Inc
California
– -$11.6M -3,133,224 Closed
BlackRock
4
BlackRock
New York
– -$10.1M -2,729,571 Closed
ACA
5
Avoro Capital Advisors
New York
– -$9.2M -2,485,272 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$7.87M -2,125,480 Closed
PC
7
Polar Capital
United Kingdom
– -$7.03M -1,900,000 Closed
SH
8
Sandia Holdings
Connecticut
– -$3.43M -927,264 Closed
A
9
Abingworth
United Kingdom
– -$3.42M -925,000 Closed
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
– -$3.24M -875,618 Closed
TCM
11
Tekla Capital Management
Massachusetts
– -$2.74M -740,769 Closed
SFM
12
Sphera Funds Management
Israel
– -$2.52M -681,210 Closed
Goldman Sachs
13
Goldman Sachs
New York
– -$2.46M -664,386 Closed
RG
14
Redmile Group
California
– -$2.4M -649,446 Closed
State Street
15
State Street
Massachusetts
– -$1.89M -511,169 Closed
KCM
16
Kennedy Capital Management
Missouri
– -$1.83M -493,561 Closed
Northern Trust
17
Northern Trust
Illinois
– -$1.45M -391,781 Closed
Geode Capital Management
18
Geode Capital Management
Massachusetts
– -$1.44M -389,041 Closed
Boston Partners
19
Boston Partners
Massachusetts
– -$1.41M -380,143 Closed
LCM
20
Laurion Capital Management
New York
– -$965K -260,710 Closed
BCM
21
Bridgeway Capital Management
Texas
– -$889K -240,215 Closed
PAWC
22
P.A.W. Capital
Connecticut
– -$740K -200,000 Closed
OAM
23
Oxford Asset Management
United Kingdom
– -$683K -182,202 Closed
EIM
24
Essex Investment Management
Massachusetts
– -$567K -153,180 Closed
Bank of New York Mellon
25
Bank of New York Mellon
New York
– -$542K -146,549 Closed
1
2 3 4

CASC Hedge Fund Activity: Q1 2018 in Review

1 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Cascadian Therapeutics, Inc. (CASC) for Q1 2018, worth a combined $0 — down 100% from $152M a quarter earlier.

Sellers outnumbered buyers: 90 funds closed out of CASC and 0 opened new positions — a net loss of 90 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was NEA Management Company, exiting entirely with an estimated $33.5M sold.

  • 1 institutional investor held Cascadian Therapeutics, Inc. (CASC) as of Q1 2018, down from 91 in Q4 2017.
  • Funds reported $0 of Cascadian Therapeutics, Inc. stock for Q1 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Cascadian Therapeutics, Inc. positions in Q1 2018 and 90 closed out, a net change of -90 holders.
  • The largest Cascadian Therapeutics, Inc. seller in Q1 2018 was NEA Management Company, an estimated $33.5M sold.

Based on aggregated 13F filings for Q1 2018.